BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gatti M, Maino C, Darvizeh F, Serafini A, Tricarico E, Guarneri A, Inchingolo R, Ippolito D, Ricardi U, Fonio P, Faletti R. Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment. World J Gastroenterol 2022; 28(26): 3116-3131 [PMID: 36051340 DOI: 10.3748/wjg.v28.i26.3116]
URL: https://www.wjgnet.com/1007-9327/full/v28/i26/3116.htm
Number Citing Articles
1
Hao Su, Yongguang Wei, Xiwen Liao, Guangzhi Zhu, Minhao Peng, Fang Fan, Tao Peng. Interpretation of the updates of the chinese guidelines for the diagnosis and treatment of primary liver cancer (CNLC-2024 Edition)Hepatoma Research 2024;  doi: 10.20517/2394-5079.2024.70
2
Andreea-Elena Scheau, Sandra Oana Jurca, Cristian Scheau, Ioana Gabriela Lupescu. Non-Surgical Treatment for Hepatocellular Carcinoma: What to Expect at Follow-Up Magnetic Resonance Imaging—A Pictorial ReviewApplied Sciences 2024; 14(20): 9159 doi: 10.3390/app14209159
3
Cesare Maino, Federica Vernuccio, Roberto Cannella, Laura Cristoferi, Paolo Niccolò Franco, Marco Carbone, Francesco Cortese, Riccardo Faletti, Elisabetta De Bernardi, Riccardo Inchingolo, Marco Gatti, Davide Ippolito. Non-invasive imaging biomarkers in chronic liver diseaseEuropean Journal of Radiology 2024; 181: 111749 doi: 10.1016/j.ejrad.2024.111749
4
Weilang Wang, Shuhang Zhang, Binyan Zhong, Wu Cai, Lei Gao, Binrong Li, Dandan Yao, Yuan Zhao, Ziying Sun, Shuwei Zhou, Teng Zhang, Xunjun Chen, Shenghong Ju, Yuan-Cheng Wang. Dynamic changes of radiological and radiomics patterns based on MRI in viable hepatocellular carcinoma after transarterial chemoembolizationAbdominal Radiology 2024;  doi: 10.1007/s00261-024-04676-z